Financials

  • Market Capitalization 6.81 M
  • Employee 5
  • Founded 2018
  • CEO N/A
  • Website www.ernexatx.com
  • Headquarter Delaware, United States
  • FIGI BBG000CX5677
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.01
ratio cours/chiffre d'affaires
376.2

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4826
INM
InMed Pharmaceuticals Inc. - Common Shares
1.30 USD-0.76%-4.41%-10.96%-39.53%7.14 M USD
4828
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.52 USD+5.12%-11.37%+1865.22%-45.41%7.09 M USD
4844
AIM
AIM ImmunoTech Inc. Common Stock
0.22 USD-4.35%-4.35%-15.38%-91.57%6.70 M USD
4848
LEXX
Lexaria Bioscience Corp. - Common Stock
3.97 USD-1.98%-64.20%-33.28%+230.83%6.56 M USD

Nouvelles